Enzyme activator

Detailed Insights on Glucokinase - H2 2020 Pipeline Review - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 6, 2021
Pharmaceutical, Health, Oncology, Branches of biology, Glucokinase, Hexokinase, Chemistry, Biochemistry, GCK, Enzyme, Glucose, Kinase, Enzyme activator

The "Glucokinase - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Glucokinase - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules.
  • The latest report Glucokinase - Pipeline Review, H2 2020, outlays comprehensive information on the Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
  • Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Glucokinase is an enzyme that catalyzes the initial step in utilization of glucose by the beta-cell and liver at physiological glucose concentration.

Glucokinase - Pipeline Review, H2 2019 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 20, 2020
Health, Pharmaceutical, Branches of biology, Proteins, Hormones, Glucokinase, Hexokinase, Insulin, GCK, Glucose, Enzyme activator

The "Glucokinase - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Glucokinase - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Hepatic glucokinase helps to facilitate the uptake and conversion of glucose by acting as an insulin-sensitive determinant of hepatic glucose usage.
  • Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 11 molecules.
  • The latest report Glucokinase - Pipeline Review, H2 2019, outlays comprehensive information on the Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

MS SEDCO'S NexGen Door Activator Switches Go Wireless

Retrieved on: 
Friday, July 6, 2018
Activator, Enzyme activator, Warranty, NexGen, Chemistry, California

INDIANAPOLIS, July 6, 2018 /PRNewswire-iReach/ -- MS SEDCO opens the door to the next generation of door activator switches as they introduce wireless versions of their NexGen Series of infrared touchless and capacitive touch door activators, the NGS-IR-A , NGS-CT-HSS and NGS-CT-P.

Key Points: 
  • INDIANAPOLIS, July 6, 2018 /PRNewswire-iReach/ -- MS SEDCO opens the door to the next generation of door activator switches as they introduce wireless versions of their NexGen Series of infrared touchless and capacitive touch door activators, the NGS-IR-A , NGS-CT-HSS and NGS-CT-P.
  • It's a one-piece door actuator with absolutely no moving pieces, which means no parts to replace or repair, and the five-year battery life makes it lower maintenance than any other door activator on the market.
  • The NexGen wireless door activators are controlled by MS SEDCO's state-of-the-art S-COR coordinator which allows for superior operation in a smaller unit.
  • The NexGen series of wireless door activator switches are available throughout the U.S. and internationally at mssedco.com and they are covered by a one-year manufacturer's warranty that covers defects in materials and workmanship.